Barclays Raises Quest Diagnostics' Price Target to $154 From $144, Maintains Equalweight Rating
Barclays Raises Quest Diagnostics' Price Target to $154 From $144, Maintains Equalweight Rating
巴克莱银行将奎斯特诊疗的目标价从144美元上调至154美元,并维持中性评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册